综述 Review

肺转移瘤的外科治疗进展

Published at: 2015年第35卷第1期

沈建飞 1 , 杨成林 1 , 何建行 1
1 广州医科大学第一附属医院胸外科,广州 510120
通讯作者 建行 何 Email: drjianxing.he@gmail.com
DOI: 10.3978/j.issn.2095-6959.10.3978/j.issn.2095-6959.2015.01.025
基金:

摘要

肺转移瘤切除是胸外科的常规手术,作为晚期癌症患者个体化治疗一部分正逐渐递增。据报道, 转移瘤切除术后的5年生存率为30%~50%。由于缺乏随机对照试验(randomised controlled trial, RCT),转移瘤切除的疗效只能基于回顾性研究进行评价。本文就目前关于肺转移瘤切除的外科治 疗现状进行综述。


Advances in surgical treatment of pulmonary metastases

Abstract

Pulmonary metastasectomy is a commonly performed operation, and as part of personalised treatment for advanced cancer is gradually increasing. Five-year survival rates of 30%~50% are recorded. In the absence of randomized trials, the efficacy of pulmonary metastasectomy only be evaluated by retrospective studies. In this review, we summarized the current treatment of pulmonary metastases.


comments powered by Disqus

全文

引用

引用本文: 建飞 沈, 成林 杨, 建行 何. 肺转移瘤的外科治疗进展[J]. 临床与病理杂志, 2015, 35(1): 106-110.
Cite this article as: SHEN Jianfei, YANG Chenglin, HE Jianxing . Advances in surgical treatment of pulmonary metastases[J]. Journal of Clinical and Pathological Research, 2015, 35(1): 106-110.